Postinflammatory Hyper- and Hypopigmentation: Differential Diagnosis and Practical Treatment Approaches
Post-inflammatory hyperpigmentation and hypopigmentation can be tricky to treat. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Pooja Sodha, associate professor of dermatology at GW School of Medicine & Health Sciences. Watch as Dr. Sodha outlines her strategies for treating post-inflammatory hyperpigmentation (PIH) and hypopigmentation. Learn why it� …
Post-inflammatory hyperpigmentation and hypopigmentation can be tricky to treat. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Pooja Sodha, associate professor of dermatology at GW School of Medicine & Health Sciences. Watch as Dr. Sodha outlines her strategies for treating post-inflammatory hyperpigmentation (PIH) and hypopigmentation. Learn why it� … 
Which histologic subtype of the lesion shown is most aggressive?
A. Solid
B. Nodular
C. Superficial
D. Morpheaform
E. All are equal
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers.
… 
Psoriasis is one of the most common immune-mediated inflammatory dermatoses, with increasing evidence for systemic comorbidities. Targeted systemic agents have revolutionized the management of moderate-to-severe psoriasis, with life-changing outcomes for many patients with the chronic disease. Injectable biologics, blocking interleukin (IL)-23 or IL-17 cytokine pathways, have become invaluable opt … 
Dermatologist Dr. Amy Weschler’s new venture with her daughter Zoe is making news this month. According to ELLE and The New York Times, the pair recently opened Spotless, a consumer-focused acne clinic. (Similar to a blow-dry bar.) Located in a Manhattan storefront, Spotless is a ground-floor, one-stop-shop for acne care, from corticosteroid injections to prescription treatments. Dr. Weschler sa … 
We’re closing out 2025 with an immunodermatology–focused issue of the Journal of Drugs in Dermatology. From incretin-based therapies for hidradenitis suppurativa (HS) to real-world data on cardiometabolic risk in inflammatory skin disease, these Editor’s Picks connect skin and systemic health with practical pearls for clinic.
GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A …